BOLT Lithotripsy RESTORE ATK Trial

计划入组 97 人 · 首次发布于 2022 年 12 月 23 日

PMCF Study for Peripheral Arteries Above the Knee (ATK)

计划入组 387 人 · 首次发布于 2022 年 4 月 5 日

Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant Community

计划入组 1,310 人 · 首次发布于 2022 年 9 月 28 日

AT6

AT1

ATP

C₁₀H₁₆N₅O₁₃P₃

SANTHERA PHARMACEUTICALS (USA), INC.

United States

Santhera Pharmaceuticals (Schweiz) AG

Switzerland

Santhera Pharmaceuticals (Deutschland) GmbH

Germany

AngioSafe's Santreva-ATK Receives FDA Clearance for Peripheral Artery Disease Treatment

Bolt Medical's IVL System Shows Promise in RESTORE ATK and BTK Trials for PAD

VIVA24: Novel Therapies Show Promise in Vascular Disease Treatment